We Are Randox | Biosciences Placement Student Kathryn Wilson
For our 2018/19 placement students, their year with Randox is almost at an end.
To mark their time with us and wish them the best of luck with their future studies, we took the opportunity to speak with one of our placement students in the sales team, to give us an insight of her experience during a Randox placement year.
Meet Kathryn Wilson, Business Placement Sales Executive for Randox Biosciences.
Hi Kathryn, can you tell us a little bit about yourself?
I am a 21-year-old student studying Bsc Equine and Veterinary Bioscience at Aberystwyth University in Wales. In September 2018 I began working in the Biosciences division of Randox Laboratories, specifically working on the release of new molecular technologies for clinical diagnostics. As part of a newly formed sales team, my focus is on the diagnostics market in Ireland.
Why did you want to forge a career in sales?
Whilst studying my bio-veterinary degree my only focus had been on science, so I was keen to broaden my horizons and explore opportunities in a business role for a company involved in the life-sciences industry. Initially, I was tentative of a role in sales, but I knew it would be a good way to develop a broad knowledge of business and the industry, and develop new skills.
Why did you decide to take your placement year with Randox?
Randox was a perfect fit for me, as a global scientific company based in Northern Ireland. I was looking for a placement that would allow me to spend time at home before returning to Wales for university.
I was intrigued by their range of products and diverse market presence in industries such as pharmaceuticals, biotech, research and healthcare. It seemed like a good company to gain an insight into new research in a variety of career sectors.
Describe a typical day as a Business Placement Sales Executive.
My role has evolved as we have moved through the different stages of product development throughout the year. Initially, when I first joined the team, we were in the planning stage. This involved mapping potential contacts and key sites in Ireland, and developing a sales strategy.
As this is a new venture for Randox the role also involved educating the market on our technology and creating awareness in all potential points of sale. This educational aspect of my job involved regular trips and meetings across Ireland, and frequent UK team meetings to discuss market feedback and problem solve. It’s important that we have been able to adapt our sales strategy for the specific healthcare areas -from public to private and point-of-care to large laboratories. Coming into the final month of my placement we are now prepared for product release with confirmed validation studies and initial placements, and significant interest across Ireland.
What are some examples of the tasks and responsibilities of your role?
There has been a range of ongoing tasks throughout the year to facilitate a busy and growing division. I was given the responsibility of forecasting, logging orders and organising meetings, and have been involved in internal decision-making processes alongside management. I have also helped to manage the university contracts in Ireland for our lab equipment, reagents and outsourcing some testing for specific studies.
Before I finish my placement I’m researching the market for upcoming arrays for launch next year, and planning a final trip in Ireland.
What was the most exciting part of your placement with Randox Biosciences?
The opportunity to travel around Ireland and London has been excellent. To date I have participated in over 10 conferences on behalf of Randox. Highlights for me have been corporate hospitality with potential customers at the Randox Health Grand National, and presenting at the first Infectious Disease Forum for Randox, in front of representatives from microbiology sites across Ireland.
I was also trusted to conduct a trip on my own around Donegal and Sligo, coupled with a visit to our Donegal R&D site, Randox Teoranta in Dungloe, to learn about future veterinary arrays in development.
It has been a privilege to be able to work with such a diverse range of people – from the scientists developing the products, to the sales team specialising in markets across the globe. There are so many different career paths here at Randox.
What has been the most challenging aspect of your time at Randox Biosciences?
I have been challenged to quickly adapt to the business environment and gain an in-depth understanding of the wide range of products. I have been pushed outside my comfort zone to discuss with customers, present to the team and take responsibility of the day-to-day tasks.
Knowing the new molecular diagnostics range, infectious disease panels, and competitors in the market well enough to be confident in front of potential customers on my own, has also been a challenge. Hard work at Randox is acknowledged however, and I was awarded runner-up Business Student of the Year.
What is the best thing about Randox and would you recommend this placement to other students?
The best thing about a placement with Randox is that you will be given as many opportunities as you are willing to take. They are very supportive and will push you as much as any other member of the team.
As a non-business student this year has given me a wealth of insight into the workings of a global company, as well as furthering my scientific knowledge and interests in many aspects of the industry.
I would recommend a Randox placement for students who are keen to gain as much experience as possible in a global company focused on new and exciting health research.
What are your goals for the future?
My experience at Randox has given me an excellent insight into the world of business in the biosciences industry, and has prepared me well to build a career in this exciting industry. I think that the experience gained through Randox will be applicable to many life sciences sectors which I would like to explore further.
Although I am not sure what the future may hold, in the shorter term I am looking forward to returning to finish my final year at Aberystwyth.
For more information about Randox Biosciences and what career opportunities we offer please contact email@example.com
Causeway Chamber, in partnership with principle sponsor Randox Health, hosted the 2019 Causeway Coast and Glens Business Awards, which was held Friday 21st June at the Lodge Hotel, Coleraine. As all enjoyed the drinks reception from Old Bushmills Distillery, the evening provided a chance to network whilst the anticipation grew before the awards presentation.
This prestigious ceremony recognised and honoured the best of the Borough’s businesses on a local and national level.
In the opening address Murray Bell, President of Causeway Chamber said;
“We have a wealth of businesses within our borough, organisations large and small, entrepreneurs, start-up innovators, all who compete at the highest level they can, and tonight is an opportunity to celebrate those talents – recognising the progress made and reaching forward to further excellence and creativity, underpinning our Chambers message that Causeway Coast & Glens Borough is an ‘Outstanding Place to live, work and play.”
350 guests attended the event including Mayor Cllr Sean Bateson, Deputy Vice Chancellor Alastair Adair, Chief Executive David Jackson, Dr Peter FitzGerald CBE FREng DL, Managing Director, Randox Laboratories Ltd, local businesses, award sponsors and the 61 finalists who eagerly waited to see if they were successful as winners of their category.
Dr Peter FitzGerald CBE FREng DL, Managing Director, Randox commented;
“It is a great honour to be here once again for the Business Awards for the Causeway Coast and Glens, a region with whom we have become closely engaged since opening the newest division of our multi-faceted company; Dundarave Estate in Bushmills. Dundarave’s collection of jams, chutneys, ciders and meats has proved very popular with both the local community and other businesses, together with whom we are able to demonstrate what Northern Ireland has to offer to a global business market.
“We are proud that through our sponsorship of this event, we can not only bring together the best local businesses, support one another and celebrate our collective achievements, but also encourage all those involved to proactively think about their health. For all of us, our health is our wealth, and indeed for the entrepreneurial finalists, many of whom are self-employed, their health is their livelihood. We might all usefully consider how we can live better for longer, to fully enjoy what life has to offer, in both our business and our personal lives. I must also say that we have been very impressed with the nominees of each category and the calibre of finalists, each of whom absolutely deserve their place in the Causeway Coast and Glens Business Awards. Congratulations to all the award winners.”
Sarah Travers who was delighted to once again host the event said;
“The Causeway Coast and Glens Borough is unique in its ability to offer a variety of locations for business development. The Chamber has truly embraced the diversity of the local business talents and rewarded each sector individually.”
Annette Deighan, Chamber Operations Manager added;
“Causeway Coast and Glens Business Awards would not have been possible without our businesses and continued support of all our sponsors. It is an honour to host these awards, to recognise the achievements and success in our region. It shows as a Borough we are continuing to excel and compete at a regional and national level.”
There were 18 awards comprising of many categories sponsored by individual companies. The judges were overwhelmed with the level of entries received which is a testament to the success of these biennial awards and the achievements of all businesses within the Borough. The awards highlighted that the Causeway Coast and Glens Borough is continuing to grow, compete and provide services at a local and global level. Congratulations to all the winners and finalists on the evening.
For further information about the Causeway Coast & Glens Business Awards 2019 please contact the Randox PR team by emailing firstname.lastname@example.org or phoning 028 9442 2413
A Queen’s University Belfast student has won the top spot in global healthcare diagnostics company Randox Laboratories’ annual Student Placement Awards.
Pearce Allingham from Andersonstown, who is studying Medicinal Chemistry, was not only placed first in the Science category but was also crowned Best Overall Placement Student.
Since September 2018, Pearce had been working alongside the scientific team in the New Technology Evaluation department, taking part in the development of Randox’s newest and most classified innovations.
Speaking at the awards ceremony at Randox Laboratories HQ in Crumlin on Friday 14th June 2019, Pearce commented,
“I’m so pleased to have won this award. I couldn’t recommend a placement at Randox highly enough and it has allowed me to see what I’m capable of when I apply myself to a field I’m passionate about. From day one I was made to feel like a scientist within the team – not just a placement student – and it’s amazing that some of my contributions are helping to advance Randox’s diagnostic capabilities further. I look forward to applying my new knowledge and skills in final year and to forging a career in research – maybe even back here at Randox.”
Randox Laboratories welcomes over 60 placement students through its doors each year across Science, Engineering and Business-related disciplines, including Sales and Marketing. The company is keen to continue to maintain its reputation as a key placement provider in Northern Ireland, as explained by Linda Magee, Operations Director at Randox Laboratories.
“We host many high calibre placement students at Randox each year and the Randox Placement Awards is the pinnacle in highlighting the fantastic contribution that these students make. Pearce, in particular, impressed us with his work ethic and initiative in one of Randox’s most cutting-edge R&D teams. Gaining industry experience is vital for young people and that is why we pride ourselves on the range of placement opportunities we provide here, especially through the Randox APEX programme which offers students a paid summer placement between first and second year, a paid placement year in third year and, finally, a graduate position on completion of their degree with a 2:1 classification. It really is the complete career package for any aspiring student.”
David Boyd, a QUB Engineering student from Belfast, won in the Engineering category of the Randox Placement Awards while Andrew Wilson, an Ulster University student from Bangor, was placed first in the Business category.
David Boyd, Engineering Placement Award winner, commented,
“As part of the Engineering team, the opportunities I’ve been given here have been second-to-none and I look forward to completing my Master’s degree in Mechanical Engineering. I used to think I would go on to work in the energy sector with renewables and nuclear but my time in Randox has shown me a different industry which I would love to return to.”
Andrew Wilson, Business Placement Award winner, also said,
“Being given the same responsibilities as the rest of your colleagues is a great way to learn quickly as you get immersed in live projects and real business. One of the most interesting aspects for me was the opportunity to travel to Hamburg and Chicago for customer visits and conferences. Dealing with different departments such as manufacturing, finance and logistics, along with my own sales and marketing team, has given me an insight in to the workings of an international company which has been an invaluable experience.”
Randox Placement Awards 2019 results
1 Andrew Wilson (Marketing, Randox Food Diagnostics), an Ulster University student from Bangor
2 Kathryn Wilson (Sales, Randox Biosciences), an Aberystwyth University student from Larne
3 Adam Donnelly – (Marketing, Randox Corporate), an Ulster University student from Bellaghy
1 Pearce Allingham (Chemistry), a Queen’s University Belfast student from Andersonstown
2 Rachel McCloy (Biotechnology), a Liverpool John Moore’s University student from Ballymena
3 Thomas Smith-Zaitlik (Molecular), a Nottingham Trent University student from Henley-on-Thames.
1 David Boyd (Engineering Design, Mechanical), a Queen’s University Belfast student from Belfast
2 Reuben Cotton (Engineering Design, Mechanical), an Ulster University student from Lisburn
3 Niall Devlin (Engineering Design, Software)
Overall Randox Placement Awards winner: Pearce Allingham
For further information please contact the Randox PR team by emailing email@example.com or phoning 028 9442 2413
Invest in Prevention with Randox Health EveryBusiness
Employee Health and welling strategies are being increasingly introduced by companies. Research in Right Management’s The flux report: Building a resilient workforce in the face of flux, published in February 2014, found that 60% of HR directors recognise that employee health and wellness are key attributes to enabling businesses to achieve their strategic objectives. However, a key problem in the area of health and wellness is that it is often misunderstood. Companies view health and wellness strategies as a firefighting measure; something that is introduced when things go wrong in the company and performance slides.
This view is narrow and to a certain extent wrong. The old saying “Prevention rather than cure” is extremely fitting within these situations. Health and wellbeing should not be about reactive illness management and employers shouldn’t wait until their employees become stressed or ill then seek to cure. Instead they should look at a prevention strategy.
Proactive Health and Wellbeing
Early intervention really does matter. Businesses that spend more time promoting wellbeing and resilience see an upturn in performance, engagement and productivity. If they also use specific data gathering and measurement throughout the year, they can demonstrate the effect of the wellbeing programmes that they’ve implemented and learn what works for them. Health and wellbeing programmes can see an 80% improvement in organisational performance, which is a huge benefit to any business.
In addition, businesses that make a commitment to employee wellbeing can also expect a return in areas such as psychological contract, improved sense of wellbeing, resilience and enhanced positive regard for the employer. Everyone has potential to be healthy, efficient, productive and happy at work. People just need the right support. With an ageing population, it is important that organisations start to recognise this. Read our blog on why to invest in employee health and the benefits.
Randox Health EveryBusiness
Our EveryBusiness corporate service aims to provide a unique health and wellbeing service for your business. EveryBusiness will benefit you and your employees and improve the productivity of your business. Our EveryBusiness service is for employers trying to improve the health and wellbeing of their employees and by doing so benefit from the results of creating a unique health and wellbeing environment.
Visit www.randoxhealth.com or phone 0800 2545 130
Randox is a placement-friendly business and we’re proud to be a top employer when it comes to students searching for their perfect placement opportunity before final year. Ulster University Business Studies student Lauren Todd joined the Randox sales team in September 2017 as a placement student, finishing with us in June 2018.
We were delighted to attend a ceremony at Ulster University’s Jordanstown campus last week where Lauren was shortlisted for a UU Placement Award. We caught up with her after the ceremony;
Lauren, congratulations on your award! Can you tell us about your university and career path to date?
During my first two years of university, I worked in retail as a cash office supervisor before leaving in the summer of 2017 to start into my placement year at Randox. I am now in my final year at UUJ and working as a private tutor to A-Level Business Studies students.
Why Randox and how did you find your placement year?
Randox is a globally recognised company with a very close links with Ulster University, and I wanted to complete my placement year with a company that would help me develop my skills outside of the classroom. I thoroughly enjoyed my placement year at Randox and it has allowed me to improve my ‘soft’ skills such as communication, teamwork and problem solving.
What was a typical day like for you at Randox?
A typical day at Randox consisted of daily communication with the global sales team, continual analysis of CRM data and the teams sales figures, compiling reports and providing feedback to the team.
How are you finding being back in university for final year?
Final year has been tough, but it’s scary that we only have six weeks left! My placement year at Randox has enabled me to become a more confident individual, and this has helped with final year projects such as group tasks and class presentations.
What was the award that you were presented with today and how are you feeling about it?
I was commended in the Excellence in Employability Awards from the Ulster University Business School. I am proud to have been shortlisted for this award as Randox have allowed me to develop my skills and helped me to work to my full potential. It feels amazing to gain this recognition from Ulster and that my contribution to the company has been beneficial.
What are your plans for after you leave university?
After graduation, I am looking forward to a few weeks off – and a much-needed two week holiday to Portugal – before starting into a full time graduate job.
To find out more about placement opportunities with Randox, please contact firstname.lastname@example.org.
The Ireland-U.S. Council in America have this week presented the founder of healthcare diagnostics company Randox Laboratories with an award marking significant achievement in building relations between Northern Ireland and the United States of America.
Presented to Dr Peter FitzGerald at the 56th Annual Dinner of the Ireland-U.S. Council yesterday evening, the accolade, named the Cúchulainn award, recognizes the efforts of individuals who go above and beyond to support the objectives of the Ireland-U.S. Council – to improve the business bonds and commercial connections between Ireland, Northern Ireland and the United States.
Joining an exclusive line-up of some of the most prominent business figures in both Ireland and the United States recognized by the Ireland-U.S. Council, including CEO of International Airlines Group William Walsh, Dr FitzGerald was presented with the prestigious award at The Metropolitan Club in New York City.
Dr. Peter FitzGerald, Founder and Managing Director of Randox Laboratories, commented;
“I am most honoured to be here this evening to accept the Cúchulainn award from the Ireland-U.S. Council in recognition of the work undertaken by Randox in the United States since the early 1980s when we began to export our diagnostic healthcare products. The United States remains one of Randox’s most important markets, in which we are growing at pace thanks to the ongoing development of innovative new products in not only the healthcare sector, but also the veterinary, research, toxicology and food safety industries.”
The Ireland-U.S. Council was founded in 1962 by a group of American and Irish business leaders as a measure to build an established structure which would encourage closer economic relations, and was initially created to assist in making preparations for the first-ever State Visit of a sitting U.S. President to Ireland by President John F. Kennedy from June 26 – 29 in 1963.
David O’Sullivan, Executive Director of the Ireland–U.S. Council, added;
“Ever since the State Visit to Ireland by President John F. Kennedy, the Ireland-U.S. Council has been engaged in efforts to achieve our transatlantic mission. Dr FitzGerald of Randox Laboratories truly embodies the essence of this mission by aligning his business in Ireland closely with businesses in the US, to maximise the positive outcomes for both parties. We are delighted to present him this evening with the Cúchulainn award – for the significant contributions he has made to the development of closer economic, business and commercial ties between our two nations.”
For further information please email email@example.com
Absenteeism has long been a problem in business. There are a variety of reasons why employees may be absent but one of the most common is illness. Employees lose an average of 30.4 working days a year due to sickness or underperforming at work due to ill health, according to research by VitalityHealth.
Its 2017 Britain’s Healthiest Workplace report, which surveyed 31,950 employees, found that productive working days lost due to physical and mental health issues cost the UK economy approximately £77.5 billion a year.
At Randox Health, we’re aiming to change the statistics and help employees to live healthier for longer. Our innovative health checks can detect disease and irregularity at the earliest stage, allowing lifestyle changes to be made now when potential illness can still be reversed.
Having a healthier workforce, conscious of how their lifestyle choices are affecting them, has been proven to encourage productivity and decrease absenteeism. Poor employee productivity is just as damaging to the workplace economy as absenteeism. One of the main causes of low productivity is poor health.
Take care of your staff with an Everybusiness programme at Randox Health. The gift of health is invaluable and will not only allow employees to enjoy the benefits of the world’s most comprehensive health programme available, but will also save your business time and money.
Our health checks are the most advanced blood screening packages available in the world as we use our patented Biochip Array Technology. Using this technology, hundreds of individual blood tests can be carried out on a single sample, allowing you to have truly unrivalled knowledge about your health both now and in the future.
We specialise in wellbeing, assessing up to 350 elements of your body and allowing early identification of illness before problems develop.
For more information on the EveryBusiness offering from Randox Health, please contact firstname.lastname@example.org or phone 0800 2545 130.
Leading diagnostics firm Randox Laboratories has this week sent a delegation of scientists from its Biosciences Division to take part in the UK Exhibition of Oncology Excellence, between 25th and 29th June in Beijing and Guangzhou, in China.
The centrepiece of the UK-China Oncology Congress, the exhibition has been carefully curated to follow the “Science to Patient Pathway” for new therapies – from research to clinical trials, regulatory approval, manufacturing and distribution.
The Randox Biosciences team, over the course of the Congress event, will join a range of cancer-related seminars, offering an opportunity to learn about and influence Chinese government policies and priorities, and explore the latest trends and hot topics in oncology.
Julie-Ann O’Hare, Sales and Marketing Director for Randox Biosciences, commented;
“At Randox Biosciences we are actively seeking opportunities to strengthen business ties between the UK and China, and of course to showcase our innovative diagnostic capabilities to what is one of our most important and growing markets.
“We continue to expand our business presence there thanks to the ongoing pipeline of novel tests being produced from our innovative research and development programmes and enhanced manufacturing capabilities, including new facilities at the Randox Science Park in Northern Ireland.”
Exhibiting to a diverse audience of universities, hospitals, and laboratories responsible for prevention, diagnosis, treatment and care in oncology, Randox Biosciences have joined the exhibition to showcase their innovative diagnostic tests for bladder cancer and early detection of renal toxicity – including Chronic Kidney Disease and Acute Kidney Injury.
“We continue to offer an increasing range of innovative diagnostic biomarkers to the growing and dynamic biotechnology markets.
“The focus on the importance of scientific research in the patient pathway, in enabling cancer diagnoses as soon as possible, offers us the perfect platform to introduce to China our latest pioneering oncological tests, including our test for bladder cancer.
“This test can stratify patients with haemeaturia (blood in the urine), who are at high risk of bladder cancer – reducing the number of unnecessary cystoscopies carried out on patients identified as ‘low risk’, significantly reducing healthcare costs and improving the waiting times for haematuria patients.”
For further information about the UK-China Oncology Congress, please email email@example.com
Randox Laboratories are pleased to announce that Managing Director Dr Peter FitzGerald has been named as the Irish Times’ Business Person of the Month for February 2018.
The award follows an announcement from Randox that the company will be investing £50m into three new Centres of Excellence in Northern Ireland, which will deliver cutting-edge technologies to diagnose conditions like cancer, heart conditions and infectious diseases.
At the time of the announcement, Dr FitzGerald commented;
“Enabling earlier and more accurate diagnosis, to identify those at the earliest stages of illness, ideally before the onset of any symptoms, is a game-changer. Through early intervention we can restrict the development of chronic conditions and improve people’s lives. Our view of the future is one where people are empowered through earlier diagnosis to stay healthier for longer, and where healthcare systems are freed to deliver quality services to patients. Our announcement today demonstrates our continuing commitment in this field.”
Scientists from the Antrim-headquartered group will work collaboratively with researchers and scientists from both Queen’s University and Ulster University in the new centres, which were launched at the new Randox Science Park by Sir John Bell.
In addition to the Randox Science Park, Randox has manufacturing, and research and development operations in Antrim, Donegal, India and the United States, and employs more than 1400 people across the globe.
Having been focused in the field of clinical diagnostics for over 36 years, Randox has a successful track record of developing new and innovative tests – examples include assessing those at risk of Alzheimer’s disease and genetic cardiac conditions, to promote and enable preventive treatment, and a new clinically-approved test to diagnose prediabetes.
Each year 5% of the world’s population – more than 370 million people in 145 countries – receive a health diagnosis via a product manufactured by Randox.
For further information please contact the Randox PR team by emailing firstname.lastname@example.org or phoning 028 9442 2413.
Off the back of its key involvement in this month’s prestigious China Summit held in Belfast, global diagnostics company Randox Laboratories has this week taken a delegation of representatives to China to reach out to existing and potential business partners.
Having exported its diagnostic products to China for over 25 years, the healthcare firm cites the country as one of its most important markets, and regularly hosts conferences and training events in the capital city for its vast distributor network.
Earlier this year, following 18 months of extensive market research and infrastructural developments, Randox launched a new market expansion initiative in China to help strengthen business relationships and increase exports – a programme which Global Sales Manager Susan Hammond credits with having accelerated demand for Randox products.
Susan Hammond, who manages Randox’s expansion in the Chinese market commented;
“At Randox we actively seek to strengthen the ties between Northern Ireland and China, and the recent China Summit in Belfast goes to show that relationships between our two countries are at an all-time high.
“We’re delighted to have had the opportunity to contribute to the discussions around collaborative opportunities in economic development, education, health and life sciences at the China Summit and to share our personal success story in the Chinese market.
“The summit marks a significant milestone in Northern Ireland’s relationship with China, and its very existence is testament to the success of the innovative market strategies of key businesses and institutions across NI.”
As well as meeting with business partners across China this week, Randox also hosted over 250 guests at performances by world-famous concert pianist and International Tchaikovsky competition winner Barry Douglas, in the Forbidden City Concert Hall of Beijing and in the Shanghai Conservatory of Music.
“Our sponsorship of Barry Douglas and his Camerata Ireland orchestra is important for the work we undertake in promoting Northern Ireland to Chinese audiences. We can showcase not only the science and innovation that come from our shores, but also the breadth of cultural talent.
“Hosting Chinese delegates, corporates, and academic professionals at Barry Douglas performances in China provides us with the perfect platform to help build connections and identify areas for business collaboration. It is a rare opportunity to be able to visit key business partners while simultaneously supporting our young musicians in their careers.”
Barry Douglas, Founder and Artistic Director of Camerata Ireland said;
“I am thrilled to be here in China to play for our Chinese guests – there is nothing quite like music in its ability to connect with people from all walks of life across the globe. It is a pleasure to be able to use music as a vehicle for strengthening relationships in both business and the arts, and even more so to be able to share it with the wonderfully generous team from Randox.”
For further information about Randox’s expansion in the Chinese market, please contact Randox PR by phoning 028 9445 1016 or emailing RandoxPR@randox.com